Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study.

Silvia GrazziniEdoardo Conticini Paolo FalsettiMiriana D'AlessandroJurgen SotaRiccardo TerribiliCaterina BaldiClaudia FabianiElena BargagliLuca CantariniBruno Frediani

Published in: Biologics : targets & therapy (2023)

Our study demonstrates the superiority in terms of rapidity of a tocilizumab-based scheme over a methotrexate-based scheme in inducing clinical and US remission. Precocious withdrawal of glucocorticoids did not increase the risk of relapse.

Keyphrases

rheumatoid arthritis
end stage renal disease
newly diagnosed
high dose
ejection fraction
chronic kidney disease
peritoneal dialysis
rheumatoid arthritis patients
disease activity
systemic lupus erythematosus
patient reported outcomes
patient reported